摩根士丹利-日本制药行业投资者演示报告-Investor PresentationJapan Pharmaceuticals-20260409_第1页
摩根士丹利-日本制药行业投资者演示报告-Investor PresentationJapan Pharmaceuticals-20260409_第2页
摩根士丹利-日本制药行业投资者演示报告-Investor PresentationJapan Pharmaceuticals-20260409_第3页
摩根士丹利-日本制药行业投资者演示报告-Investor PresentationJapan Pharmaceuticals-20260409_第4页
摩根士丹利-日本制药行业投资者演示报告-Investor PresentationJapan Pharmaceuticals-20260409_第5页
已阅读5页,还剩74页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

MorganstanleyMUFGFouNDATloN

April9,202608:03AMGMT

InvestorPresentation|Japan

Pharmaceuticals

lTopPick:DaiichiSankyo

lOW(Preferenceorder):DaiichiSankyo,Takeda,Otsuka,ChugailOW(Mid-capandgeneric):KakenandSawaiGroupHoldings

llndustryView:ln-Line

MoRGANSTANLEyMUFGSEcuRiTiEsCo.,LTd.+ShinichiroMuraoka

EquityAnalyst

Shinichiro.Muraoka@

+8136836-5424

JaeheonLeeEquityAnalyst

Jaeheon.Lee@

+8136836-8443

PHARmAcEuTicALs

Japan

IndustryViewIn-Line

MorganStanleydoesandseekstodobusinesswith

companiescoveredinMorganStanleyResearch.Asaresult,investorsshouldbeawarethatthefirmmayhaveaconflictofinterestthatcouldaffecttheobjectivityofMorganStanley

Research.InvestorsshouldconsiderMorganStanley

Researchasonlyasinglefactorinmakingtheirinvestmentdecision.

Foranalystcertificationandotherimportantdisclosures,refertotheDisclosureSection,locatedattheendofthisreport.

+=Analystsemployedbynon-U.S.affiliatesarenotregisteredwithFINRA,maynotbeassociatedpersonsofthememberandmaynotbesubjecttoFINRArestrictionson

communicationswithasubjectcompany,publicappearancesandtradingsecuritiesheldbyaresearchanalystaccount.

2

MorganstanleyMUFGFouNDATloN

TableofContents

Valuation/Performance3-8

PharmaceuticalIndustryStructure9-11

FXsensitivity12

Appendix:Pharmaindustryoverview13-18

SummaryforEachCompany19-36

DaiichiSankyo19

TakedaPharmaceutical20

OtsukaHD21

ChugaiPharmaceutical22

KakenPharmaceutical23

SawaiGroupHoldings24

AstellasPharma25

Eisai26

Shionogi27

SantenPharmaceutical28

Tsumura29

SanBio30

JCR31

TowaPharmaceutical32

OnoPharmaceutical33

NipponShinyaku34

KyowaKirin35

FouNDATloN

MoRGANSTANLEyMUFG3

ValuationsforOurCoverageStocks(1)

SharePriceCompanyRatingPT2026/04/08

YTD

(%)

Last4wks

MktCap(bn)

2024

2025e

2026e

EPS(Adj)2027e

2028e

2029e

2030e

2024

2025e

2026e

P/E*

2028e

2029e

2030e

EPSGrowth

2025e-30e

PEG

Ratio

2027e

TakedaOW¥6,200

¥5,789

19.7%

3.6%

¥9,211

491.2

495.7

488.2

517.1

609.0

664.8

703.5

11.8x

11.7x

11.9x

11.2x

9.5x

8.7x

8.2x

7%

1.6

AstellasEW¥2,050

¥2,624

25.4%

10.8%

¥4,749

165.2

226.5

277.0

217.9

175.7

179.1

214.7

15.9x

11.6x

9.5x

12.0x

14.9x

14.6x

12.2x

-1%

(8.9)

DaiichiSankyoOW¥4,900

¥2,833

-15.4%

0.2%

¥5,366

147.6

174.9

184.7

192.4

246.1

278.5

311.8

19.2x

16.2x

15.3x

14.7x

11.5x

10.2x

9.1x

12%

1.3

EisaiEW¥5,200

¥5,155

10.6%

7.8%

¥1,503

163.8

176.5

243.2

379.3

431.4

482.1

538.4

31.5x

29.2x

21.2x

13.6x

11.9x

10.7x

9.6x

25%

0.8

OtsukaOW¥13,200

¥11,050

24.5%

9.8%

¥6,000

633.8

685.1

565.0

683.0

739.0

779.7

636.9

17.4x

16.1x

19.6x

16.2x

15.0x

14.2x

17.3x

-1%

(13.5)

ChugaiOW¥11,750

¥8,883

7.8%

-7.3%

¥14,915

241.3

274.1

315.9

352.9

390.0

421.6

481.7

36.8x

32.4x

28.1x

25.2x

22.8x

21.1x

18.4x

12%

2.4

KyowaKirinUW¥1,700

¥2,631

4.1%

16.8%

¥1,383

121.4

161.3

175.2

174.2

158.0

154.2

158.8

21.7x

16.3x

15.0x

15.1x

16.7x

17.1x

16.6x

0%

(48.0)

ShionogiEW¥3,900

¥3,606

26.9%

5.5%

¥3,208

203.5

246.4

378.4

412.9

423.1

419.6

346.8

17.7x

14.6x

9.5x

8.7x

8.5x

8.6x

10.4x

7%

1.3

NipponShinyakuUW¥2,600

¥5,294

-6.3%

9.2%

¥372

483.4

417.8

383.7

242.7

42.3

52.7

52.7

11.0x

12.7x

13.8x

21.8x

125.2x

100.5x

100.5x

-34%

(0.4)

KakenOW¥5,200

¥4,220

5.1%

0.7%

¥186

365.4

72.7

21.7

37.5

61.1

144.9

367.6

11.5x

58.1x

194.0x

112.6x

69.1x

29.1x

11.5x

38%

5.1

OnoUW¥1,950

¥2,547

17.2%

2.6%

¥1,270

192.4

194.6

187.3

149.4

180.9

178.2

172.0

13.2x

13.1x

13.6x

17.0x

14.1x

14.3x

14.8x

-2%

(5.6)

SantenEW¥1,900

¥1,931

18.8%

20.6%

¥622

129.3

120.7

139.1

146.2

163.0

184.8

212.6

14.9x

16.0x

13.9x

13.2x

11.8x

10.5x

9.1x

12%

1.2

TsumuraEW¥4,400

¥3,838

-5.9%

-0.4%

¥295

427.1

368.9

410.8

435.8

429.2

452.9

487.2

9.0x

10.4x

9.3x

8.8x

8.9x

8.5x

7.9x

6%

1.6

JCREW¥550

¥580

-18.5%

-5.3%

¥75

(38.4)

15.3

3.2

29.1

0.8

14.5

24.2

-15.1x

37.8x

179.5x

19.9x

718.2x

39.9x

23.9x

10%

18.8

SanBioEW¥1,900

¥2,110

24.9%

-2.6%

¥165

(41.5)

(52.6)

(72.2)

(32.5)

(35.1)

(21.0)

40.6

-

-

-

-

-

-

52.0x

-

-

SawaiOW¥3,000

¥2,268

-3.9%

3.4%

¥262

137.6

160.7

193.5

219.1

238.2

259.9

284.1

16.5x

14.1x

11.7x

10.3x

9.5x

8.7x

8.0x

12%

1.0

TowaEW¥4,500

¥4,300

18.1%

3.4%

¥222

385.7

451.7

452.0

499.7

516.0

533.3

537.3

11.1x

9.5x

9.5x

8.6x

8.3x

8.1x

8.0x

4%

2.7

PharmaAvg.(Weighted)

629

22.6x

19.7x

18.7x

16.8x

17.1x

14.8x

14.1x

7%

2.8

USPharma(coveredbyTerenceFlynn)

AbbvieOW$270.0

$211.59

-7.4%

-8.0%

$374.1

$10.1

$10.0

$15.3

$17.4

$19.5

$20.7

$21.2

20.9x

21.2x

13.9x

12.1x

10.9x

10.2x

10.0x

16%

1.3

BMYUW$40.0

$59.20

9.8%

-0.8%

$120.6

$1.2

$6.1

$6.3

$5.8

$4.9

$4.2

$4.7

51.3x

9.6x

9.3x

10.3x

12.1x

14.0x

12.6x

-5%

(1.8)

JNJOW$262.0

$241.30

16.6%

0.4%

$581.2

$10.0

$10.8

$11.6

$12.9

$14.8

$16.7

$18.2

24.2x

22.3x

20.7x

18.7x

16.3x

14.4x

13.2x

11%

2.0

EliLillyOW$1,313.0

$953.30

-11.3%

-3.7%

$900.7

$13.0

$24.2

$37.1

$43.8

$55.5

$62.1

$71.3

73.4x

39.4x

25.7x

21.8x

17.2x

15.4x

13.4x

24%

1.6

MerckEW$109.0

$123.18

17.0%

7.2%

$304.5

$7.7

$8.9

$5.2

$9.9

$11.0

$8.9

$9.5

16.1x

13.8x

23.8x

12.4x

11.2x

13.8x

12.9x

1%

10.9

PfizerEW$27.0

$27.47

10.3%

1.6%

$156.2

$3.1

$3.2

$2.9

$2.7

$2.1

$2.1

$2.3

8.8x

8.5x

9.4x

10.2x

13.2x

13.3x

12.1x

-7%

(1.3)

USPharmaAvg.(Weighted)

41.2x

25.9x

20.6x

17.1x

14.8x

14.0x

12.6x

14%

1.9

EUPharma(coveredbySaritaKapilaandThibault

Boutherin)

GBp15,216

10.3%

4.9%

$317.4

$8.2

$9.2

$10.2

$11.8

$12.6

$14.3

$16.8

24.9x

22.3x

20.0x

17.3x

16.3x

14.3x

12.2x

13%

1.7

AZNOWGBp16,500

GSKUWGBp1,700

GBp2,125

10.3%

4.3%

$116.0

GBp159.4

GBp172.0

GBp182.4

GBp195.1

GBp193.7

GBp192.6

GBp185.3

13.3x

12.4x

11.7x

10.9x

11.0x

11.0x

11.5x

2%

8.2

NovartisOWCHF135

CHF121

10.6%

1.3%

$312.7

$7.8

$9.0

$8.6

$9.8

$11.2

$12.5

$13.2

19.7x

17.1x

17.8x

15.7x

13.7x

12.3x

11.6x

8%

2.1

NovoNordiskEWDKK250

DKK240

-26.2%

0.2%

$127.4

DKK22.7

DKK23.1

DKK21.5

DKK21.5

DKK21.5

DKK23.2

DKK25.6

10.6x

10.4x

11.2x

11.2x

11.1x

10.3x

9.4x

2%

5.0

RocheUWCHF295

CHF325

-3.0%

-4.7%

$323.8

CHF18.9

CHF19.6

CHF20.6

CHF21.3

CHF21.8

CHF24.1

CHF24.6

17.2x

16.6x

15.8x

15.2x

14.9x

13.5x

13.2x

5%

3.6

SanofiOWε95

ε81

-2.2%

5.9%

$114.6

ε7.1

ε7.8

ε8.6

ε9.0

ε9.9

ε11.0

ε12.0

11.4x

10.3x

9.4x

9.0x

8.1x

7.4x

6.7x

9%

1.2

EUPharmaAvg.(Weighted)

18.2x

16.6x

15.9x

14.5x

13.6x

12.4x

11.5x

7%

2.3

Biotech(coveredbyTerenceFlynn)

AmgenEW$309.0

$222.0

6.9%

-5.3%

$188.6

$19.8

$21.8

$23.4

$24.7

$27.8

$29.8

$31.8

11.2x

10.2x

9.5x

9.0x

8.0x

7.5x

7.0x

8%

1.3

GileadOW$171.0

$141.5

15.3%

-1.1%

$175.7

$4.6

$8.1

$8.5

$9.9

$10.7

$12.2

$13.7

30.5x

17.4x

16.6x

14.2x

13.3x

11.6x

10.3x

11%

1.6

BiogenEW$190.0

$179.9

2.2%

-2.7%

$26.4

$16.5

$15.3

$16.3

$14.0

$13.9

$9.8

$10.8

10.9x

11.7x

11.0x

12.9x

12.9x

18.4x

16.7x

-7%

(1.7)

VertexOW$596.0

$443.9

-2.1%

-2.8%

$112.8

$0.4

$18.5

$19.0

$21.5

$24.5

$29.1

$34.5

1046.2x

24.0x

23.4x

20.6x

18.1x

15.2x

12.8x

13%

1.8

RegeneronEW$769.0

$775.5

0.5%

2.1%

$80.6

$45.6

$44.2

$46.1

$53.0

$61.2

$69.3

$74.8

17.0x

17.5x

16.8x

14.6x

12.7x

11.2x

10.4x

11%

1.6

BiotechAvg.(Weighted)

217.6x

16.1x

15.4x

13.8x

12.4x

11.2x

10.0x

10%

1.7

Note1:ForJapanesecompanies,FYendsinMarchexcludingChugai,KyowaKirinandOtsuka(DecFY-end).Note2:EPSestimatesforKaken,Eisai,JCR,andSanBioareonareportedbasis,andEPSestimatesforothercompaniesexcludeone-offfactorsandgoodwillamortization.Note3:e=MorganStanleyResearchestimates.OW=Overweight,EW=Equal-weight,UW=UnderweightSource:FactSet,Company,MorganStanleyResearch

4

ValuationsforOurCoverageStocks(2)

SharePriceYTDLastMktCapEV(24)EV/EBITDANetDebt/EBITDAP/BDY

CompanyRatingPT2026/04/08

(%)

4wks

(bn)

(bn)

2024

2025e

2026e

2027e

2028e

2029e

2030e

2024

2025e

2026e

2027e

2028e

2029e

2030e

2024

(%)

TakedaOW¥6,200¥5,789

19.7%

3.6%

¥9,211

¥13,342

10.9x

9.7x

10.1x

9.7x

8.6x

8.0x

7.7x

3.4x

2.8x

2.7x

2.4x

1.9x

1.5x

1.2x

1.3x

3.4%

AstellasEW¥2,050¥2,624

25.4%

10.8%

¥4,749

¥5,362

21.6x

9.2x

8.0x

10.1x

12.3x

12.1x

10.2x

2.5x

0.7x

0.2x

-0.5x

-1.2x

-1.6x

-1.7x

3.1x

2.8%

DaiichiSankyoOW¥4,900¥2,833

-15.4%

0.2%

¥5,366

¥4,746

11.8x

10.9x

9.8x

9.4x

7.6x

6.8x

6.1x

-1.5x

-1.4x

-1.3x

-1.3x

-1.2x

-1.2x

-1.3x

3.3x

2.1%

EisaiEW¥5,200¥5,155

10.6%

7.8%

¥1,503

¥1,425

15.1x

14.3x

11.6x

8.4x

7.7x

7.0x

6.5x

-0.8x

-0.7x

-0.6x

-0.7x

-0.9x

-1.1x

-1.4x

1.7x

3.1%

OtsukaOW¥13,200¥11,050

24.5%

9.8%

¥6,000

¥5,637

13.1x

9.5x

10.9x

9.4x

8.7x

8.2x

9.5x

-0.8x

-0.7x

-1.1x

-1.1x

-1.3x

-1.6x

-2.1x

2.2x

1.1%

ChugaiOW¥11,750¥8,883

7.8%

-7.3%

¥14,915

¥13,919

23.9x

21.1x

18.6x

16.8x

15.3x

14.2x

12.5x

-1.7x

-1.5x

-1.7x

-1.9x

-2.2x

-2.4x

-2.5x

7.7x

1.1%

KyowaKirinUW¥1,700¥2,631

4.1%

16.8%

¥1,383

¥1,136

9.2x

8.4x

7.7x

7.7x

8.3x

8.5x

8.3x

-2.0x

-1.6x

-1.7x

-2.0x

-2.3x

-2.6x

-2.7x

1.6x

2.2%

ShionogiEW¥3,900¥3,606

26.9%

5.5%

¥3,208

¥2,833

16.0x

12.0x

6.4x

18.7x

18.7x

18.7x

18.7x

-2.1x

1.2x

0.3x

0.0x

0.0x

0.0x

0.0x

2.3x

1.7%

NipponShinyakuUW¥2,600¥5,294

-6.3%

9.2%

¥372

¥317

7.5x

7.5x

8.1x

11.6x

31.0x

28.5x

28.5x

-1.3x

-1.7x

-2.0x

-3.4x

-9.2x

-7.9x

-7.4x

1.4x

2.3%

KakenOW¥5,200¥4,220

5.1%

0.7%

¥186

¥120

5.1x

23.1x

35.3x

29.3x

22.2x

12.1x

5.5x

-2.8x

-11.6x

-16.8x

-12.1x

-8.0x

-4.1x

-2.0x

1.1x

4.5%

OnoUW¥1,950¥2,547

17.2%

2.6%

¥1,270

¥1,195

13.8x

9.9x

10.1x

11.8x

9.8x

10.0x

10.2x

-0.9x

-0.6x

-1.1x

-1.7x

-1.8x

-2.2x

-2.7x

1.5x

3.1%

SantenEW¥1,900¥1,931

18.8%

20.6%

¥622

¥559

7.2x

8.0x

7.3x

7.0x

6.4x

5.7x

5.1x

-0.8x

-1.3x

-1.6x

-1.9x

-2.1x

-2.3x

-2.4x

2.3x

1.9%

TsumuraEW¥4,400¥3,838

-5.9%

-0.4%

¥295

¥292

5.3x

5.7x

5.1x

4.7x

4.6x

4.4x

3.9x

-0.1x

1.1x

2.2x

2.8x

3.4x

3.7x

3.6x

1.1x

3.5%

JCREW¥550¥580

-18.5%

-5.3%

¥75

¥100

-30.6x

25.0x

23.8x

11.6x

23.8x

15.9x

12.8x

-7.6x

5.9x

5.7x

2.7x

5.7x

4.1x

3.5x

1.5x

3.4%

SanBioEW¥1,900¥2,110

24.9%

-2.6%

¥165

¥167

-

-

-

-

-

-

39.5x

-0.7x

-3.7x

-1.2x

-0.9x

-0.3x

0.9x

0.2x

84.9x

0.0%

SawaiOW¥3,000¥2,268

-3.9%

3.4%

¥262

¥313

16.2x

8.6x

6.5x

5.9x

5.4x

5.0x

4.6x

2.7x

0.7x

0.7x

0.8x

0.7x

0.6x

0.4x

1.5x

2.3%

TowaEW¥4,500¥4,300

18.1%

3.4%

¥222

¥393

10.1x

8.7x

7.9x

7.4x

7.3x

7.1x

7.0x

4.4x

3.7x

3.0x

2.4x

2.0x

1.7x

1.4x

1.2x

1.6%

PharmaAvg.(Weighted)

16.5x

13.2x

12.0x

12.1x

11.4x

10.8x

10.2x

-0.1x

-0.2x

-0.4x

-0.7x

-0.9x

-1.2x

-1.3x

4.1x

USPharma(coveredbyTerenceFlynn)

AbbvieOW$270$211.59

-7.4%

-8.0%

$374.13

$435.7

18.1x

17.8x

12.6x

11.0x

9.9x

9.4x

9.2x

2.6x

2.3x

1.2x

0.9x

0.4x

0.0x

-0.4x

112.3x

3.0%

BMYUW$40.00$59.20

9.8%

-0.8%

$120.6

$159.3

27.2x

10.4x

9.3x

9.7x

11.3x

12.8x

11.8x

6.6x

2.3x

1.7x

1.5x

1.3x

1.3x

1.0x

7.3x

4.1%

JNJOW$262.00$241.30

16.6%

0.4%

$581.2

$593.3

20.3x

17.8x

16.2x

15.0x

13.3x

11.9x

11.1x

0.4x

1.0x

0.6x

0.2x

-0.3x

-0.6x

-1.1x

8.1x

2.0%

EliLillyOW$1,313.00$953.30

-11.3%

-3.7%

$900.7

$930.9

60.0x

32.5x

22.0x

19.1x

15.2x

13.6x

11.9x

1.9x

0.8x

0.3x

0.0x

-0.4x

-0.8x

-1.1x

60.5x

0.5%

MerckEW$109.00$123.18

17.0%

7.2%

$304.5

$328.0

12.9x

11.4x

16.1x

10.2x

9.5x

11.6x

11.1x

0.9x

1.1x

1.6x

0.7x

0.3x

0.1x

-0.1x

6.7x

2.5%

PfizerEW$27.00$27.47

10.3%

1.6%

$156.2

$200.1

8.5x

8.5x

8.8x

9.5x

11.9x

12.0x

11.2x

1.9x

1.9x

2.0x

1.9x

2.2x

2.2x

1.9x

1.8x

6.1%

USPharmaAvg.(Weighted)

33.3x

21.5x

16.9x

14.7x

12.8x

12.2x

11.2x

1.8x

1.3x

0.8x

0.4x

0.1x

-0.2x

-0.6x

42.8x

EUPharma(coveredbySaritaKapilaandThibaultBoutherin)

AZNOWGBp16,500GBp15,216

10.3%

4.9%

$317.4

$342.2

19.3x

17.7x

15.5x

13.8x

13.1x

11.7x

10.1x

1.4x

1.2x

0.8x

0.3x

-0.2x

-0.7x

-1.1x

7.8x

1.5%

GSKUWGBp1,700GBp2,125

10.3%

4.3%

$116.0

$129.0

10.6x

10.0x

9.4x

8.8x

8.9x

9.0x

9.4x

1.3x

1.3x

1.3x

1.0x

0.8x

0.6x

0.4x

6.3x

2.8%

NovartisOWCHF135CHF121

10.6%

1.3%

$312.7

$328.8

15.9x

14.2x

14.6x

13.0x

11.7x

10.7x

10.3x

0.8x

0.9x

1.5x

1.2x

0.9x

0.5x

0.3x

5.6x

2.9%

NovoNordiskEWDKK250DKK240

-26.2%

0.2%

$127.4

$197.5

5.5x

5.4x

5.5x

5.4x

5.3x

5.0x

4.7x

0.5x

0.7x

0.8x

0.6x

0.5x

0.4x

0.2x

4.8x

4.1%

RocheUWCHF295CHF325

-3.0%

-4.7%

$323.8

#VALUE!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

#VALUE!

SanofiOW€95€81

-2.2%

5.9%

$114.6

$123.5

8.3x

7.8x

7.2x

7.0x

6.4x

5.8x

5.4x

0.7x

0.8x

0.7x

0.5x

0.2x

-0.1x

-0.4x

1.3x

4.7%

EUPharmaAvg.(Weighted)

10.7x

9.8x

9.2x

8.4x

7.8x

7.2x

6.7x

0.7x

0.8x

0.8x

0.5x

0.3x

0.0x

-0.2x

4.3x

Biotech(coveredbyTerenceFlynn)

AmgenEW$309.00$222.02

6.9%

-5.3%

$188.6

$236.7

15.1x

13.9x

13.0x

12.7x

11.9x

11.5x

11.1x

3.1x

2.7x

2.3x

1.8x

1.3x

0.8x

0.3x

20.3x

4.0%

GileadOW$171.00$141.54

15.3%

-1.1%

$175.7

$192.4

21.6x

14.2x

13.1x

11.5x

10.9x

9.7x

8.7x

1.9x

1.3x

0.5x

-0.3x

-0.9x

-1.5x

-2.0x

9.2x

2.2%

BiogenEW$190.00$179.90

2.2%

-2.7%

$26.4

$30.3

9.3x

9.7x

9.2x

10.5x

10.8x

14.5x

13.4x

1.2x

0.5x

-0.1x

-1.0x

-1.9x

-3.4x

-3.9x

1.6x

0.0%

VertexOW$596.00$443.92

-2.1%

-2.8%

$112.8

$106.7

118.2x

19.3x

18.3x

16.1x

14.2x

11.9x

10.1x

-6.8x

-1.5x

-2.3x

-2.8x

-3.3x

-3.6x

-3.9x

7.0x

0.0%

RegeneronEW$769.00$775.53

0.5%

2.1%

$80.6

$73.6

13.2x

13.9x

13.4x

11.4x

9.7x

8.6x

8.0x

-1.3x

-1.1x

-1.4x

-1.6x

-1.8x

-2.0x

-2.4x

2.9x

0.0%

BiotechAvg.(Weighted)

36.4x

14.8x

13.9x

12.7x

11.7x

10.8x

9.8x

0.1x

0.8x

0.3x

-0.3x

-0.8x

-1.3x

-1.7x

11.1x

Note1:ForJapanesecompanies,fiscalyearendsinMarchexcludingChugai,KyowaKirinandOtsukaHD(DecFY-end).Note2:e=MorganStanleyResearch,OW=Overweight,EW=Equal-weight,UW=Underweight.

Source:FactSet,Company,MorganStanleyResearch,RefertothefollowingslidesforindustryviewforUS.

MoRGANSTANLEyMUFG5

OW:Largecap:DaiichiSankyoTakeda,OtsukaHDandChugai.Mid-cap:Kaken.Generic:Sawai

StreetView:Ratings

AsteııasOnoSantenTakedaEisaiChugaiShionogiKakenTsumuraJCRSanBioSawaiTowa

MSRatingOWEWUWUWUWEWOWEWOWOWEWOWEWEWEWOWEW

PriceTarget4,900.002,050.001,950.001,700.002,600.001,900.006,200.005,200.0013,200.0011,750.003,900.005,200.004,400.00550.001,900.003,000.004,500.00

CurrentPrice(2026/4/8)2,8332,6242,5472,6315,2941,9315,7895,15511,0508,8833,6064,2203,8385802,1102,2684,300

Upside/Downside73%-22%-23%-35%-51%-2%7%1%19%32%8%23%15%-5%-10%32%5%

MarketCap(USDmn)33,145USD31,760USD7,505USD8,628USD2,234USD4,829USD56,479USD9,112USD36,563USD91,591USD19,218USD1,009USD1,840USD448USD1,112USD1,767USD1,326USD

AvgDailyTradedVol(USDmn)148USD80USD32USD19USD10USD12USD137USD40USD67USD133USD45USD4USD11USD4USD43USD5USD3USD

Buy/Overweight94%29%8%17%50%60%63%27%62%63%36%25%25%0%0%78%67%

Hold/Equal-weight6%64%69%33%38%40%31%67%38%31%64%75%75%100%80%11%33%

Sell/Underweight0%7%23%50%13%0%6%7%0%6%0%0%0%0%20%11%0%

DaiichiKyowaNipponOtsuka

SankyoKirinShinyakuHD

SharePricePerformancein2024

Tsumura77%

OtsukaHD63%

Towa43%

Kaken35%

Chugai31%

Sawai24%

S-Pharma21%

Santen15%

D-Sankyo12%

SanBio7%

Takeda3%

KyowaKirin0%

Shionogi-2%

Astellas-9%

N-Shinyaku-20%

Ono-35%

Eisai-39%

JCR-48%

-80%-40%0%40%80%

SharePricePerformancein2025

S-Pharma

SanBio125%

N-Shinyaku42%

Astellas36%

Ono33%

Shionogi28%

Chugai18%

JCR17%

Takeda16%

Sawai10%

Towa8%

Eisai8%

KyowaKirin6%

OtsukaHD3%

Santen0%

Kaken-11%

Tsumura-13%

D-Sankyo-23%

-60%-10%40%90%140%

YTDSharePricePerformanceasof2026/4/8

27%25%25%25%

20%

19%

18%

17%

11%8%

5%

4%

-4%

-6%

-6%

-8%

-15%

-19%

Shionogi Astellas SanBioOtsukaHD Takeda SantenTowa

Ono

Eisai Chugai KakenKyowaKirin Sawai TsumuraN-Shinyaku S-Pharma D-SankyoJCR

-30%-20%-10%0%10%20%30%

Source:FactSet,MorganStanleyResearch,Note:OW=Overweight,EW=Equal-weight,UW=Underweight

+

6

Pharma:ValuationComparison(vsGlobalPharma,vsTOPIX)

P/Etrends:Japan,USandEUPharma

2026/03/31

JPPharmaEUPharmaUSPharma

P/E(x)

45

40

35

30

25

20

15

10

5

Source:FactSet,MorganStanleyResearch,Note:JPPharmaP/EareweightedavgofourcoverageP/Ebasedonour1-1.5yrforwardEPSestimates

TOPIX-relativeP/EofJapanPharma

PharmaIndustryRelativeP/E(vsTOPIX)

32026/03/312.5

2

1.5

1

0.5

0

StockPerformance:Japan,USandEUPharma

2026/03/31

EUPharmaJPPharmaUSPharma

450

400

350

300

250

200

150

100

50

Note:JapanPharma=TOPIXPharma.USPharma=S&PPharmaIndustryIndex.EuropePharma=FactSetPharma.12/30/1999=100.Source:FactSet,MorganStanleyResearch

Ourviewonthepharmaceuticalindustry

Japan

In-Line

US

MajorPharma:In-Line

Biotech:Attractive

EU

In-Line

Source:FactSet,MorganStanleyResearch

MoRGANSTANLEyMUFG

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论